Ignite Creation Date:
2024-05-06 @ 8:07 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02677337
Status:
COMPLETED
Last Update Posted:
2017-02-17
First Post:
2016-02-03
Brief Title:
NCCN Renal Cell Registry
Sponsor:
Duke University
Organization:
Duke University
Study Overview
Official Title:
Novel Educational Interventions for Community Oncologists Patients Optimizing Renal Cell Carcinoma Outcomes Through Engagement
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will consist of three parts 1 a retrospective chart review of patients treated for mRCC from July 2013 until the start of the educational intervention 2 an educational program for DCN community oncology providers and DCN community patients with mRCC lasting 8 - 10 months and 3 a second retrospective chart review of patients treated for mRCC starting at the time of the educational intervention until the intervention is completed
Detailed Description:
The initial retrospective cohort will serve as the pre-education control and the second cohort will be the experimental group to assess the efficacy of the educational intervention to change care of patients with mRCC
Chart Reviews This study will begin with a multi-site chart review conducted at the Duke Cancer Network affiliated sites The chart review will begin in late fall 2015 The Duke Cancer Network team will perform chart abstraction for this study with a goal of reviewing at least 60 charts of patients treated between July 2013 and October 2015
The second data collection period will collect data on patients with mRCC seen at DCN sites after the date in fall 2015 when the educational intervention is rolled out The target will again be at least 60 charts of patients treated during the time the educational intervention is actively available
Chart Reviews This study will begin with a multi-site chart review conducted at the Duke Cancer Network affiliated sites The chart review will begin in late fall 2015 The Duke Cancer Network team will perform chart abstraction for this study with a goal of reviewing at least 60 charts of patients treated between July 2013 and October 2015
The second data collection period will collect data on patients with mRCC seen at DCN sites after the date in fall 2015 when the educational intervention is rolled out The target will again be at least 60 charts of patients treated during the time the educational intervention is actively available
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None